Treatment of hantavirus pulmonary syndrome

Colleen Jonsson, Jay Hooper, Gregory Mertz

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Viruses in the genus Hantavirus can cause one of two serious illnesses when transmitted from rodents to humans: hemorrhagic fever with renal syndrome (HFRS) or hantavirus pulmonary syndrome (HPS). Of the two diseases, HPS is more severe with an approximate 40% mortality across the Americas. The high rate of mortality could be reduced if effective therapeutics could be discovered for treatment of this illness. Herein we review approaches being explored for the discovery of therapeutics for HPS and how they could be employed in treatment and prevention of disease.

Original languageEnglish (US)
Pages (from-to)162-169
Number of pages8
JournalAntiviral Research
Volume78
Issue number1
DOIs
StatePublished - Apr 1 2008

Fingerprint

Hantavirus Pulmonary Syndrome
Hantavirus
Hemorrhagic Fever with Renal Syndrome
Mortality
Rodentia
Viruses
Therapeutics

All Science Journal Classification (ASJC) codes

  • Virology
  • Pharmacology

Cite this

Treatment of hantavirus pulmonary syndrome. / Jonsson, Colleen; Hooper, Jay; Mertz, Gregory.

In: Antiviral Research, Vol. 78, No. 1, 01.04.2008, p. 162-169.

Research output: Contribution to journalArticle

Jonsson, Colleen ; Hooper, Jay ; Mertz, Gregory. / Treatment of hantavirus pulmonary syndrome. In: Antiviral Research. 2008 ; Vol. 78, No. 1. pp. 162-169.
@article{c03fcbf3a79a4443aea5ec187d0c939e,
title = "Treatment of hantavirus pulmonary syndrome",
abstract = "Viruses in the genus Hantavirus can cause one of two serious illnesses when transmitted from rodents to humans: hemorrhagic fever with renal syndrome (HFRS) or hantavirus pulmonary syndrome (HPS). Of the two diseases, HPS is more severe with an approximate 40{\%} mortality across the Americas. The high rate of mortality could be reduced if effective therapeutics could be discovered for treatment of this illness. Herein we review approaches being explored for the discovery of therapeutics for HPS and how they could be employed in treatment and prevention of disease.",
author = "Colleen Jonsson and Jay Hooper and Gregory Mertz",
year = "2008",
month = "4",
day = "1",
doi = "10.1016/j.antiviral.2007.10.012",
language = "English (US)",
volume = "78",
pages = "162--169",
journal = "Antiviral Research",
issn = "0166-3542",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Treatment of hantavirus pulmonary syndrome

AU - Jonsson, Colleen

AU - Hooper, Jay

AU - Mertz, Gregory

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Viruses in the genus Hantavirus can cause one of two serious illnesses when transmitted from rodents to humans: hemorrhagic fever with renal syndrome (HFRS) or hantavirus pulmonary syndrome (HPS). Of the two diseases, HPS is more severe with an approximate 40% mortality across the Americas. The high rate of mortality could be reduced if effective therapeutics could be discovered for treatment of this illness. Herein we review approaches being explored for the discovery of therapeutics for HPS and how they could be employed in treatment and prevention of disease.

AB - Viruses in the genus Hantavirus can cause one of two serious illnesses when transmitted from rodents to humans: hemorrhagic fever with renal syndrome (HFRS) or hantavirus pulmonary syndrome (HPS). Of the two diseases, HPS is more severe with an approximate 40% mortality across the Americas. The high rate of mortality could be reduced if effective therapeutics could be discovered for treatment of this illness. Herein we review approaches being explored for the discovery of therapeutics for HPS and how they could be employed in treatment and prevention of disease.

UR - http://www.scopus.com/inward/record.url?scp=40749139151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40749139151&partnerID=8YFLogxK

U2 - 10.1016/j.antiviral.2007.10.012

DO - 10.1016/j.antiviral.2007.10.012

M3 - Article

VL - 78

SP - 162

EP - 169

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

IS - 1

ER -